Stock CAPR CAPRICOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Capricor Therapeutics, Inc.

Equities

CAPR

US14070B3096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
5.33 USD -1.48% Intraday chart for Capricor Therapeutics, Inc. +7.89% +9.00%
Apr. 24 Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug MT
Apr. 24 Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Raises Price Target on Capricor Therapeutics to $40 From $18, Keeps Buy Rating
MT
Ladenburg Thalmann Starts Capricor Therapeutics at Buy With $15 Price Target
MT
HC Wainwright Adjusts Capricor Therapeutics' Price Target to $18 From $14, Reiterates Buy Rating
MT
CAPRICOR THERAPEUTICS : HC Wainwright Boosts Price Target on Capricor Therapeutics to $14 From $9, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CAPR Stock
  4. News Capricor Therapeutics, Inc.
  5. Analyst Reco.